(NASDAQ: SGHT) Sight Sciences's forecast annual revenue growth rate of 14.65% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 12.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 57.66%.
Sight Sciences's revenue in 2026 is $76,052,000.On average, 10 Wall Street analysts forecast SGHT's revenue for 2026 to be $4,605,762,231, with the lowest SGHT revenue forecast at $4,181,413,718, and the highest SGHT revenue forecast at $5,008,591,949. On average, 9 Wall Street analysts forecast SGHT's revenue for 2027 to be $5,208,288,477, with the lowest SGHT revenue forecast at $4,450,848,059, and the highest SGHT revenue forecast at $6,097,696,736.
In 2028, SGHT is forecast to generate $6,115,673,125 in revenue, with the lowest revenue forecast at $5,875,635,466 and the highest revenue forecast at $6,295,437,010.